Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chemed Corp reaffirms FY 2014 EPS outlook


Tuesday, 29 Apr 2014 04:01pm EDT 

Chemed Corp:Expects FY 2014 earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt, litigation and other discrete items, will be in the range of $5.90 to $6.10.FY 2014 EPS of $5.90 - Thomson Reuters I/B/E/S. 

Company Quote

104.15
0.01 +0.01%
3:09pm EST